Metabolomic Diagnostics Ltd:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Metabolomic Diagnostics Ltd - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10480
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アイルランド
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Metabolomic Diagnostics Ltd (Metabolomic Diagnostics) is an early stage medical diagnostic company that develops technology to provide predictive diagnosis of pre-eclampsia in early pregnancy. The company uses metabolic profiling for investigating the low molecular weight biochemicals existing in the metabolome of a cell, tissue and organism. It provides research activities such as biobank that enables the development of predictive screening tests; and training to clinical academics, midwives, PhD students and postdoctoral fellows, among others. Metabolomic Diagnostics collaborates with universities and research institutions for the development and validation of its early pregnancy screening test for pre-eclampsia based on metabolomic biomarkers and clinical risk factors. The company operates in Ireland. Metabolomic Diagnostics is headquartered in Cork, Ireland.

Metabolomic Diagnostics Ltd – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Metabolomic Diagnostics Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Metabolomic Diagnostics Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Metabolomic Diagnostics Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Metabolomic Diagnostics Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Metabolomic Diagnostics Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Metabolomic Diagnostics Ltd, Medical Equipment, Deal Details 10
Venture Financing 10
Metabolomic Diagnostics Raises USD1.8 Million in Venture Financing 10
Metabolomic Diagnostics Secures USD0.84 million in Venture Funding 11
Metabolomic Diagnostics Raises USD0.85 Million in Venture Financing 12
Metabolomic Diagnostics Raises US$1 Million In Series A Financing 13
Metabolomic Diagnostics Secures Venture Funding from SOSventures 14
Partnerships 15
Inform Bioscience Enters into Licensing Agreement with Mayo Clinic 15
Metabolomic Diagnostics Ltd – Key Competitors 16
Metabolomic Diagnostics Ltd – Key Employees 17
Metabolomic Diagnostics Ltd – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Metabolomic Diagnostics Ltd, Medical Equipment, Key Facts 2
Metabolomic Diagnostics Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Metabolomic Diagnostics Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Metabolomic Diagnostics Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Metabolomic Diagnostics Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Metabolomic Diagnostics Ltd, Deals By Market, 2012 to YTD 2018 8
Metabolomic Diagnostics Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Metabolomic Diagnostics Raises USD1.8 Million in Venture Financing 10
Metabolomic Diagnostics Secures USD0.84 million in Venture Funding 11
Metabolomic Diagnostics Raises USD0.85 Million in Venture Financing 12
Metabolomic Diagnostics Raises US$1 Million In Series A Financing 13
Metabolomic Diagnostics Secures Venture Funding from SOSventures 14
Inform Bioscience Enters into Licensing Agreement with Mayo Clinic 15
Metabolomic Diagnostics Ltd, Key Competitors 16
Metabolomic Diagnostics Ltd, Key Employees 17
Metabolomic Diagnostics Ltd, Subsidiaries 18

List of Figures
Metabolomic Diagnostics Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Metabolomic Diagnostics Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Metabolomic Diagnostics Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Metabolomic Diagnostics Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Metabolomic Diagnostics Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Metabolomic Diagnostics Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Metabolomic Diagnostics Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Metabolomic Diagnostics Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Metabolomic Diagnostics Ltd:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Anavex Life Sciences Corp (AVXL):企業の財務・戦略的SWOT分析
    Anavex Life Sciences Corp (AVXL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Rural Areas Electricity Company SAO.C.:企業の戦略的SWOT分析
    Rural Areas Electricity Company SAO.C. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • North Energy ASA (NORTH):企業の財務・戦略的SWOT分析
    Summary North Energy ASA (North Energy) is an upstream oil and gas company that provides exploration and development services in Norwegian Continental Shelf (NCS). The company’s services include oil and gas exploration and development, license mapping and drilling programs, and conducting geological …
  • HeartWare International Inc:企業の戦略的SWOT分析
    HeartWare International Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Rich Pharmaceuticals Inc (RCHA):企業の財務・戦略的SWOT分析
    Summary Rich Pharmaceuticals Inc (Rich Pharmaceuticals) is a biopharmaceutical company that offers discovery and development of therapies for the treatment of acute myelogenous leukemia (AML) in refractory patients. The company’s pipeline portfolio offers a lead drug candidate for the treatment of a …
  • Daelim Industrial Co Ltd:戦略・SWOT・企業財務分析
    Daelim Industrial Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Daelim Industrial Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Camping World Holdings, Inc. (CWH):企業の財務・戦略的SWOT分析
    Camping World Holdings, Inc. (CWH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • ChemoCentryx Inc (CCXI):企業の財務・戦略的SWOT分析
    Summary ChemoCentryx Inc (ChemoCentryx) is a biopharmaceutical company that discovers, develops and commercializes orally-administered therapeutics for the treatment of cancer, autoimmune diseases, and inflammatory disorders. The company's lead drug candidate include Avacopan, an orally-administered …
  • Fichtner GmbH & Co KG:企業の戦略的SWOT分析
    Fichtner GmbH & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Trane Technologies Plc (TT):企業の財務・戦略的SWOT分析
    Trane Technologies Plc (TT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Angion Biomedica Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Angion Biomedica Corp (Angion) is a clinical-stage organ restoration biopharmaceutical company that discovers and develops novel treatments for the treatment of renal and chronic organ injury and disease. The company’s pipeline products include BB3, ANG-3070, ANG-3586, ANG-4201, TBD and ANG- …
  • PhotoMedex Inc (PHMD)-製薬・医療分野:企業M&A・提携分析
    Summary PhotoMedex Inc (PhotoMedex) is a medical device company that provides dermatological solutions. The company offers Neova, Tricomin and IAMIN products. Its products are used in the treatment of skin diseases and conditions such as psoriasis, vitiligo, acne, actinic keratosis. PhotoMedex provi …
  • Northrop Grumman Corp (NOC):企業の財務・戦略的SWOT分析
    Northrop Grumman Corp (NOC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Taylor Corporation:企業の戦略・SWOT・財務情報
    Taylor Corporation - Strategy, SWOT and Corporate Finance Report Summary Taylor Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Compania Espanola de Petroleos SAU:石油・ガス:M&Aディール及び事業提携情報
    Summary Compania Espanola de Petroleos SAU (CEPSA) is an integrated energy company. It explores for, produces, refines, transports, and markets and sells crude oil, petroleum products, and natural gas. The company also generates and sells electricity and thermal power to industrial customers and con …
  • RWE AG:企業の戦略・SWOT・財務情報
    RWE AG - Strategy, SWOT and Corporate Finance Report Summary RWE AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Crownhaitai Holdings Co Ltd:企業の戦略・SWOT・財務分析
    Crownhaitai Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Crownhaitai Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Asterand Bioscience Inc-製薬・医療分野:企業M&A・提携分析
    Summary Asterand Bioscience Inc (Asterand) is a biopharmaceutical company that offers tissue based products and contract research services. The company offers human tissue and human tissue-based research solutions to drug discovery scientists. Its products include biospecimens, human tissue and biof …
  • Darling Ingredients Inc.:企業のM&A・事業提携・投資動向
    Darling Ingredients Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Darling Ingredients Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Fluxion Biosciences Inc:医療機器:M&Aディール及び事業提携情報
    Summary Fluxion Biosciences Inc (Fluxion) is a provider of analytical instruments for functional cellular analyses. The company’s liquid biopsy technologies include IsoFlux CTC liquid biopsy system, ERASE-Seq variant caller for liquid biopsies and the Spotlight 59 for ultra-sensitive NGS mutation de …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆